P1179: EFFECTIVENESS OF CENTRAL NERVOUS SYSTEM PROPHYLAXIS STRATEGIES IN DIFFUSE LARGE B‐CELL LYMPHOMA von Eraslan, F. Z., Toptas, T., Tuglular, T., Atagunduz, I.

Volltext

REAL‐LIFE EXPERIENCE WITH RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐da‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): A MULTINATIONAL ANALYSIS OF 274 PATIENTS von Vassilakopoulos, T., Ferhanoglu, B., Horowitz, N., Mellios, Z., Kaynar, L., Zektser, M., Symeonidis, A., Piperidou, A., Giotas, A., Agathocleous, A., Kalpadakis, C., Akay, O., Atalar, S., Katodritou, E., Leonidopoulou, T., Papageorgiou, S., Tadmor, T., Gutwein, O., Karakatsanis, S., Ganzel, C., Karianakis, C., Isenberg, G., Gainaru, G., Vrakidou, E., Palassopoulou, M., Ozgur, M., Siakantaris, M., Paydas, S., Tsirigotis, P., Tsirogianni, M., Hatzimichael, E., Tuglular, T., Chatzidimitriou, C., Megalakaki, E., Kanellias, N., Zikos, P., Koumarianou, A., Gafter‐Gvili, A., Angelopoulou, M., Karmiris, T., Gurion, R.

Volltext

RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): REAL‐LIFE EXPERIENCE ON 190 PATIENTS FROM 3 MEDITERRANEAN COUNTRIES von Vassilakopoulos, T., Ferhanoglu, B., Horowitz, N., Mellios, Z., Kaynar, L., Zektser, M., Symeonidis, A., Piperidou, A., Kalpadakis, C., Akay, O. M., Atalar, A. C., Katodritou, E., Leonidopoulou, T., Papageorgiou, S., Tadmor, T., Gutwein, O., Karakatsanis, S., Ganzel, C., Karianakis, G., Isenberg, G., Gainaru, G., Vrakidou, E., Palassopoulou, M., Ozgur, M., Siakantaris, M., Paydas, S., Tsirigotis, P., Tsirogianni, M., Hatzimichael, E., Tuglular, T., Chatzidimitriou, C., Megalakaki, E., Kanellias, N., Zikos, P., Koumarianou, A., Gafter‐Gvili, A., Angelopoulou, M., Karmiris, T., Gurion, R.

Volltext

Nivolumab for relapsed or refractory Hodgkin lymphoma: Experience in Turkey von Ferhanoglu, B., Bekoz, H., Karadurmus, N., Paydas, S., Gulbas, Z., Turker, A., Toptas, T., Firatli Tuglular, T., Tekgunduz, E., Kaya, A., Tastemir, N., Arat, M., Pepedil Tanrikulu, F., Ozkocaman, V., Abali, H., Turgut, M., Kaynar, L., Karadogan, I., Ozbalak, M., Dogu, M., Kabukcu Hacioglu, S., Yildirim, R., Barista, I., Kurt Yuksel, M., Sonmez, M.

Volltext

Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience von Beköz, H., Karadurmuş, N., Paydaş, S., Türker, A., Toptaş, T., Fıratlı Tuğlular, T., Sönmez, M., Gülbaş, Z., Tekgündüz, E., Kaya, A.H., Özbalak, M., Taştemir, N., Kaynar, L., Yıldırım, R., Karadoğan, I., Arat, M., Pepedil Tanrıkulu, F., Özkocaman, V., Abalı, H., Turgut, M., Kurt Yüksel, M., Özcan, M., Doğu, M.H., Kabukçu Hacıoğlu, S., Barışta, I., Demirkaya, M., Köseoğlu, F.D., Toprak, S.K., Yılmaz, M., Demirkürek, H.C., Demirkol, O., Ferhanoğlu, B.

Volltext

P1227: POLATUZUMAB VEDOTIN, RITUXIMAB, AND BENDAMUSTINE COMBINATION IN RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: A REAL‐WORLD DATA FROM TURKEY von Dal, M. S., Uncu Ulu, B., Uzay, A., Akay, O. M., Besisik, S., Yenerel, M. N., Celik, S., Kaynar, L., Yucel, O. K., Deveci, B., Sonmez, M., Mehtap, O., Bekoz, H. S., Sunu, C., Salim, O., Ulas, T., Karti, S., Altuntas, F., Ferhanoglu, B., Firatli Tuglular, T.

Volltext

P1229: RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): REAL‐LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES von Vassilakopoulos, T., Ferhanoglu, B., Horowitz, N. A., Apostolidis, J., Mellios, Z., Kaynar, L., Zektser, M., Symeonidis, A., Piperidou, A., Kalpadaki, C., Akay, O. M., Atalar, S. C., Sayyed, A., Katodritou, E., Leonidopoulou, T., Papageorgiou, S., Tadmor, T., Gutwein, O., Karakatsanis, S., Ganzel, C., Karianakis, G., Isenberg, G., Gainaru, G., Vrakidou, E., Palassopoulou, M., Ozgur, M., Siakantaris, M., Paydas, S., Tsirigotis, P., Tsirogianni, M., Hatzimichael, E., Tuglular, T. F., Chatzidimitriou, C., Liaskas, A., Lefaki, M. A., Kanellias, N., Zikos, P., Koumarianou, A., Gafter‐Gvili, A., Angelopoulou, M., Karmiris, T., Gurion, R.

Volltext

Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA von Ortiz, Alberto, Cozzolino, Mario, Fliser, Danilo, Fouque, Denis, Goumenos, Dimitrios, Massy, Ziad A, Rosenkranz, Alexander R, Rychlık, Ivan, Soler, Maria Jose, Stevens, Kate, Torra, Roser, Tuglular, Serhan, Wanner, Christoph, Gansevoort, Ron T, Duivenvoorden, Raphaël, Franssen, Casper F M, Hemmelder, Marc H, Hilbrands, Luuk B, Jager, Kitty J, Noordzij, Marlies, Vart, Priya

Volltext

893 RATE AND TYPE OF LIVER INJURY AFTER BMT MAY DEPEND ON THE CONDITIONING REGIMEN IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES von Alahdab, Y, Aktas, B, Kaygusuz, I, Gunduz, F, Kedrah, A, Cetiner, M, Tuglular, T, Bayik, M, Ozdogan, O, Tozun, N

Volltext

Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association von Ortiz, Alberto, Wanner, Christoph, Gansevoort, Ron

Volltext

Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association von Ortiz, Alberto, Wanner, Christoph, Gansevoort, Ron

Volltext

Distribution, preparedness and management of Ukrainian adult refugees on dialysis—an international survey by the Renal Disaster Relief Task Force of the European Renal Association... von Pawłowicz-Szlarska, Ewa, Vanholder, Raymond, Sever, Mehmet S, Tuğlular, Serhan, Luyckx, Valerie, Eckardt, Kai-Uwe, Gallego, Daniel, Ivanov, Dmytro, Nistor, Ionut, Shroff, Rukshana, Škoberne, Andrej, Stuard, Stefano, Gellert, Ryszard, Noruišiene, Edita, Sekkarie, Mohamed, Wiecek, Andrzej

Volltext

Effects of single‐agent bortezomib as post‐transplant consolidation therapy on multiple myeloma‐related bone disease: a randomized phase II study von Sezer, Orhan, Beksac, Meral, Hajek, Roman, Sucak, Gülsan, Cagirgan, Seckin, Linkesch, Werner, Meltem Akay, Olga, Gülbas, Zafer, Nahi, Hareth, Plesner, Torben, Snowden, John A., Timurağaoğlu, Ayşen, Dechow, Tobias, Lang, Alois, Tuğlular, Tülin, Drach, Johannes, Armbrecht, Gabriele, Potamianou, Anna, Couturier, Catherine, Olie, Robert A., Feys, Caroline, Allietta, Nathalie, Terpos, Evangelos

Volltext

PB1953 QUALITY OF LIFE AND SYMPTOM BURDEN WITH FIRST AND SECOND GENERATION TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA von Toptas, T., Bostan, H., Kut, K., Pepedil Tanrikulu, F., Yilmaz, F., Atagunduz, I., Tuglular, T.

Volltext

Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association von Ortiz, Alberto, Wanner, Christoph, Gansevoort, Ron

Volltext

PB1947 COMPARISON OF EFFICACY AND SIDE EFFECTS OF SECONDLINE DASATINIB AND NILOTINIB THERAPIES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE RESISTANT OR INTOLERANT TO... von Kaygusuz Atagunduz, I., Gecgel Arikan, F., Memis, T., Toptas, T., Yilmaz, F., Ipek, Y., Elibol, T., Tuglular, T.

Volltext

Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib Mesylate von Kaygusuz Atagunduz, I, Toptas, T, Deniz, R, Kara, O, Eser, A, Sezgin, A, Ozgumus, T, Gecgel, F, Firatli Tuglular, T

Volltext

Thrombophilia and inflammatory bowel disease: does factor V mutation have a role? von Hamzaoglu Över, Hülya, Ülgen, Sertag, Tuglular, Tülin, Tezel, Ahmet, Avsar, Erol, Geyik, Göksel, Bangui, Senem, Sayhan, Nur, Ulusoy, Nefise, Kalayci, Cem, Tözün, Nurdan

Volltext

PB2235 SYMPTOM BURDEN AND SPLEEN SIZE RESPONSE WITH RUXOLUTINIB IN A REAL‐LIFE TURKISH COHORT von Tuglular, T., Arikan, F., Ercan, T., Elibol, T., Okcu, D., Ipek, Y., Ozgumus, T., Sezgin, A., Yilmaz, F., Atagunduz, I., Toptas, T.

Volltext

215 AZACYTIDINE IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA von Tuglular, T. Firatli, Tanrikulu, F. Pepedil, Atagunduz, I. Kaygusuz, Kara, O, Sezgin, A, Ozgumus, T, Eser, A, Toptas, T

Volltext